Investment and impact fund supports DOACs

Two new primary care network (PCN) investment and impact Fund (IIF) indicators for 2022/23 have been announced; CVD-05 encourages more atrial fibrillation (AF) patients to be treated with direct acting oral anticoagulants (DOACs) and CVD-06 encourages, where clinically appropriate, more patients treated with DOACs to be prescribed edoxaban.
Source: NHS Networks - Category: UK Health Source Type: news